Source: Cardiovascular Therapeutics. Unidades: FM, CEPEUSP
Subjects: DISPNÉIA, RESPIRAÇÃO ARTIFICIAL, DOENÇA CRÔNICA, PEPTÍDEO NATRIURÉTICO ATRIAL, INSUFICIÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOCCHI, Edimar Alcides et al. Effects of the Recombinant Form of the Natural Human B-type Natriuretic Peptide and Levosimendan on Pulmonary Hyperventilation and Chemosensivity in Heart. Cardiovascular Therapeutics, v. 31, n. 2, p. 100-107, 2013Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5922.2011.00297.x/pdf. Acesso em: 06 nov. 2024.APA
Bocchi, E. A., Moura, L. Z., Issa, V. S., Cruz, F., Carvalho, V. O., & Guimarães, G. V. (2013). Effects of the Recombinant Form of the Natural Human B-type Natriuretic Peptide and Levosimendan on Pulmonary Hyperventilation and Chemosensivity in Heart. Cardiovascular Therapeutics, 31( 2), 100-107. doi:10.1111/j.1755-5922.2011.00297.xNLM
Bocchi EA, Moura LZ, Issa VS, Cruz F, Carvalho VO, Guimarães GV. Effects of the Recombinant Form of the Natural Human B-type Natriuretic Peptide and Levosimendan on Pulmonary Hyperventilation and Chemosensivity in Heart [Internet]. Cardiovascular Therapeutics. 2013 ; 31( 2): 100-107.[citado 2024 nov. 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5922.2011.00297.x/pdfVancouver
Bocchi EA, Moura LZ, Issa VS, Cruz F, Carvalho VO, Guimarães GV. Effects of the Recombinant Form of the Natural Human B-type Natriuretic Peptide and Levosimendan on Pulmonary Hyperventilation and Chemosensivity in Heart [Internet]. Cardiovascular Therapeutics. 2013 ; 31( 2): 100-107.[citado 2024 nov. 06 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5922.2011.00297.x/pdf
